Mei Pharma

Developer of targeted therapies for the treatment of cancer

placeSan Diego, California, United States calendar_todayFounded 2000 groups46 employees language meipharma.com

Registered entities

Innovation

41 patent families (20 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace slowing. Cited 6,994 times.

YearFilings
20157
20169
20175
20188
201911
202017
202117
202213
202311
202411
20256
20261

Social engagement

Social engagement: 4.8K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

23 investors on record; lead investors include Array, GSR; 2 have since exited.

Investor typeCountShare
Venture capital1043%
Private equity522%
Other / undisclosed835%

Recent activity

24 Jun 2026
Event
Litecoin Summit
19 Jun 2026
Event
Litecoin Foundation Summit panel on Litecoin's institutional opportunity
Coming soon